Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 18 2026

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-feb-18-2026-3

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 18, 2026, titled "Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases